Literature DB >> 35063100

CRISPR-based genome editing through the lens of DNA repair.

Tarun S Nambiar1, Lou Baudrier2, Pierre Billon3, Alberto Ciccia4.   

Abstract

Genome editing technologies operate by inducing site-specific DNA perturbations that are resolved by cellular DNA repair pathways. Products of genome editors include DNA breaks generated by CRISPR-associated nucleases, base modifications induced by base editors, DNA flaps created by prime editors, and integration intermediates formed by site-specific recombinases and transposases associated with CRISPR systems. Here, we discuss the cellular processes that repair CRISPR-generated DNA lesions and describe strategies to obtain desirable genomic changes through modulation of DNA repair pathways. Advances in our understanding of the DNA repair circuitry, in conjunction with the rapid development of innovative genome editing technologies, promise to greatly enhance our ability to improve food production, combat environmental pollution, develop cell-based therapies, and cure genetic and infectious diseases.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35063100      PMCID: PMC8887926          DOI: 10.1016/j.molcel.2021.12.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  471 in total

1.  53BP1 fosters fidelity of homology-directed DNA repair.

Authors:  Fena Ochs; Kumar Somyajit; Matthias Altmeyer; Maj-Britt Rask; Jiri Lukas; Claudia Lukas
Journal:  Nat Struct Mol Biol       Date:  2016-06-27       Impact factor: 15.369

2.  Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.

Authors:  Benedetta Artegiani; Delilah Hendriks; Joep Beumer; Rutger Kok; Xuan Zheng; Indi Joore; Susana Chuva de Sousa Lopes; Jeroen van Zon; Sander Tans; Hans Clevers
Journal:  Nat Cell Biol       Date:  2020-03-02       Impact factor: 28.824

Review 3.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

4.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

Review 5.  Trinucleotide repeat instability during double-strand break repair: from mechanisms to gene therapy.

Authors:  Valentine Mosbach; Lucie Poggi; Guy-Franck Richard
Journal:  Curr Genet       Date:  2018-07-05       Impact factor: 3.886

6.  Breaking the code of DNA binding specificity of TAL-type III effectors.

Authors:  Jens Boch; Heidi Scholze; Sebastian Schornack; Angelika Landgraf; Simone Hahn; Sabine Kay; Thomas Lahaye; Anja Nickstadt; Ulla Bonas
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

Review 7.  Repair of DNA Double-Strand Breaks by the Nonhomologous End Joining Pathway.

Authors:  Benjamin M Stinson; Joseph J Loparo
Journal:  Annu Rev Biochem       Date:  2021-02-08       Impact factor: 27.258

8.  Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering.

Authors:  Kunwoo Lee; Vanessa A Mackley; Anirudh Rao; Anthony T Chong; Mark A Dewitt; Jacob E Corn; Niren Murthy
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

9.  Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.

Authors:  Yuxi Chen; Jiaqi Liu; Shengyao Zhi; Qi Zheng; Wenbin Ma; Junjiu Huang; Yizhi Liu; Dan Liu; Puping Liang; Zhou Songyang
Journal:  Nat Commun       Date:  2020-06-19       Impact factor: 14.919

10.  Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction.

Authors:  Changcai Huang; Guangyu Li; Jiayu Wu; Junbo Liang; Xiaoyue Wang
Journal:  Genome Biol       Date:  2021-03-10       Impact factor: 13.583

View more
  8 in total

Review 1.  Therapeutic in vivo delivery of gene editing agents.

Authors:  Aditya Raguram; Samagya Banskota; David R Liu
Journal:  Cell       Date:  2022-07-06       Impact factor: 66.850

Review 2.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 3.  Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae.

Authors:  Jacob S Antony; John M Hinz; John J Wyrick
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

Review 4.  The Challenges in Developing Efficient and Robust Synthetic Homing Endonuclease Gene Drives.

Authors:  Sebald A N Verkuijl; Joshua X D Ang; Luke Alphey; Michael B Bonsall; Michelle A E Anderson
Journal:  Front Bioeng Biotechnol       Date:  2022-03-28

5.  High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA.

Authors:  Soyoung A Oh; Kate Senger; Shravan Madireddi; Ilseyar Akhmetzyanova; Isabel E Ishizuka; Somayeh Tarighat; Jerry H Lo; David Shaw; Benjamin Haley; Sascha Rutz
Journal:  J Exp Med       Date:  2022-04-22       Impact factor: 17.579

Review 6.  A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing.

Authors:  Xin-Zhu Chen; Rong Guo; Cong Zhao; Jing Xu; Hang Song; Hua Yu; Christian Pilarsky; Firzan Nainu; Jing-Quan Li; Xin-Ke Zhou; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

7.  Editorial: Protecting the code: DNA double-strand break repair pathway choice.

Authors:  Jenny Kaur Singh; Sylvie M Noordermeer; Judit Jimenez-Sainz; David G Maranon; Matthias Altmeyer
Journal:  Front Genet       Date:  2022-08-12       Impact factor: 4.772

Review 8.  Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems.

Authors:  Faranak Hejabi; Mohammad Sadegh Abbaszadeh; Shirinsadat Taji; Andrew O'Neill; Fatemeh Farjadian; Mohammad Doroudian
Journal:  Front Chem       Date:  2022-07-26       Impact factor: 5.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.